Transparency Market Research

Transparency Market
Research
Human Reproductive Technologies Market - Global
Industry Analysis, Size, Procedures, Growth, Trends
and Forecast, 2013 - 2019
Published Date
14-April-2014
125 Page Report
Buy Now
Request Sample
Press Release
Human Reproductive Technologies Market Will Reach US$27.1 Billion by
2019: Transparency Market Research
Transparency Market Research
State Tower,
90, State Street, Suite 700.
Albany, NY 12207
United States
www.transparencymarketresearch.com
sales@transparencymarketresearch.com
Human Reproductive
Technologies Market
REPORT DESCRIPTION
Human Reproductive Technologies Market - Global Industry Analysis, Size, Procedures, Growth,
Trends and Forecast, 2013 - 2019
In the new report published by Transparency Market Research Human Reproductive Technologies Market Global Industry Analysis, Size, Procedures, Growth, Trends and Forecast, 2013 - 2019, the global human
reproductive market technologies was worth US$23.0 billion in 2012. However, according to some recent
research and statistics the overall human reproductive technologies market is growing at a CAGR 2.2%
from 2013 to 2019 and is expected to reach US$27.1 billion in 2019.
Browse the full report at
http://www.transparencymarketresearch.com/human-reproductive-technologies-market.html
In order to provide a thorough analysis of the overall competitive scenario in the global human
reproductive technologies market, this report covers every aspect of the market and analyzes it in terms of
treatment technologies, drugs, and various devices that are used to assist and control human
reproduction.
Considering the human reproductive technologies market on the basis of market segmentation, the global
market is divided into two major segments: contraceptive technologies and infertility treatments. The
report involves the study of several providers and manufacturers of contraceptive technologies and
infertility solutions too.
The contraceptive technologies market is further classified into contraceptive devices and drugs. The
contraceptive devices market is sectioned into female contraceptive devices and male contraceptive
devices (condoms), while, the contraceptive drugs market comprises topical contraceptives, contraceptive
injectables, and oral contraceptive pills.
In 2012, the global contraceptives market was worth US$16.0 billion; however, presently, the market is
expected to grow at a CAGR of 5.5% from 2013 to 2019. Among the varied contraceptive drugs, the oral
contraceptive pills market held the highest revenue in 2012 and thus, led the overall contraceptives
Human Reproductive
Technologies Market
market in the same year. The growth was also mainly due to rising awareness about oral contraceptive
pills among population through advertisements. People can buy drugs over-the-counter as well.
At the same time, the contraceptive devices market - male condoms was considered to be the largest
market segment due to awareness among population and increased accessibility with ease of use.
We are currently offering a flat 15% discount on all purchases until end of the March 2015!
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1876
Likewise, the report also provides details about the infertility technologies market which is broadly
analyzed with respect to types of treatment procedures and drugs. The types of infertility treatment
methods studied in the report include zygote intrafallopian transfer (ZIFT), intrauterine insemination (IUI),
intracytoplasmic sperm injection (ICSI), in vitro fertilization (IVF), and gamete intrafallopian transfer (GIFT).
Furthermore, with respect to infertility drugs, the market witnesses three primary classes involving certain
leading brands (by sales), namely, androgens, gonadotropins, and erectile dysfunction. Some of the other
drugs analyzed in this study report include AndroGel, Viagra, Gonal-f, Cialis, Follistim AQ, Testim, and
Levitra/Staxyn.
Among all the aforementioned drugs, Viagra was the largest drug brand (by revenue) in 2012 and has
been a renowned and approved brand by the U.S. FDA, since 1998. Owing to increasing incidences of
erectile dysfunction in male infertility, Viagra is still at a commanding position in the global infertility
market. Moreover, for testosterone deficiency, AndroGel is the most preferred drug for the treatment, and
Gonal-f under the gonadotropin class is a widely prescribed brand to achieve better results for infertility
issues.
The report study observes some of the main players in the global human reproductive technologies market
which include Merck Serono, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Abbott Laboratories,
Bayer AG, Watson Pharmaceuticals, Pfizer, Inc., and Reckitt Benckiser. Generic manufacturers such as Par
Pharmaceuticals and Watson Pharmaceuticals are expected to penetrate the global human reproductive
technologies market with their new generic versions by 2015.
North America was a dominant player in the global human reproductive technologies market in 2012 and
this region is further expected to maintain its market position till 2019. Nevertheless, the Asia-Pacific
Human Reproductive
Technologies Market
contraceptive technologies market is also growing rapidly mainly due to the rising awareness and
acceptance of human reproductive technologies in this region. The growth rate is estimated to be 6.9%
CAGR from 2013 to 2019.
The global human reproductive technologies market is categorized into the following
segments:
Human Reproductive Technologies Market, by Infertility Drugs
Gonal-f (recombinant follitropin alfa)
Follistim AQ (follitropin beta)
AndroGel (testosterone)
Testim (testosterone)
Viagra (sildenafil citrate)
Cialis (tadalafil)
Levitra/Staxyn (vardenafil)
Human Reproductive Technologies Market, by Infertility Procedures
In Vitro Fertilization (IVF)
Intracytoplasmic Sperm Injection (ICSI)
Zygote Intrafallopian Transfer (ZIFT)
Gamete Intrafallopian Transfer (GIFT)
Intrauterine Insemination (IUI)
Human Reproductive
Technologies Market
Human Reproductive Technologies Market, by Contraceptive Technologies
Drugs
Oral Contraceptive Pills
Contraceptive Injectables
Topical Contraceptives
Devices
Male Contraceptive Devices (Male Condoms)
Female Contraceptive Devices
Human Reproductive Technologies Market, by Geography
North America
Europe
Asia-Pacific
Rest of the World (RoW)
Browse More Report on Pharmaceuticals Market:

http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
TABLE OF CONTENT
Chapter 1 Introduction
1.1 Report Description
Human Reproductive
Technologies Market
1.2 Market Segmentation

1.4 Research Methodology
1.5 List of Abbreviations
Chapter 2 Executive Summary

2.1 Market Snapshot: Global Human Reproductive Technologies Market
2.2 Comparative Analysis: Global Human Reproductive Technologies Market, by Geography, 2012 & 2019
(Value %)
Chapter 3 Market Overview

3.1 Introduction and Market Definition
3.1.1 Infertility Causative Factors
3.2 Market Drivers
3.2.1 Delay in Conception
3.2.2 Rise in the Number of Infertile Population
3.2.3 Increasing Prevalence of Worldwide Obesity
3.2.4 Lifestyle Hazards such as Smoking, Stress and Pollution
3.2.5 Rising Prevalence of Unwanted Pregnancies and High Global Prevalence of Women with Unmet
Contraceptive Needs
3.2.6 Government and NGO Initiatives to Promote Contraceptive Products
3.2.7 Implementation of the Patient Protection Act or the Affordable Care Act
3.3 Market Restraints
3.3.1 Limited Insurance Coverage
3.3.2 Economic and Social Factors
Human Reproductive
Technologies Market
3.3.3 Side Effects Associated with the Use of Contraceptive Drugs and Devices
3.4 Market Opportunities
3.4.1 Rise in Medical Tourism
3.4.2 Government Support for Infertility Procedures
3.4.3 Presence of Strong Contraceptives Pipeline
3.5 Porters Five Forces Analysis for the Global Human Reproductive Technologies Market
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat of New Entrants
3.5.4 Threat of Substitutes
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Human Reproductive Technologies Market, by Geography
Chapter 4 Global Human Reproduction Technologies Market, by Infertility Treatment

4.1 Overview
4.2 Infertility Drugs
4.2.1 Global Infertility Drugs Market Revenue, by Brand, 2011 2019 (USD Million)
4.2.2 Gonal-f
4.2.2.1 Global Gonal-f Market Revenue, 2011 2019 (USD Million)
4.2.3 Follistim AQ
4.2.3.1 Global Follistim AQ Market Revenue, 2011 2019 (USD Million)
4.2.4 AndroGel
4.2.4.1 Global AndroGel Market Revenue, 2011 2019 (USD Million)
Human Reproductive
Technologies Market
4.2.5 Testim
4.2.5.1 Global Testim Market Revenue, 2011 2019 (USD Million)
4.2.6 Viagra
4.2.6.1 Global Viagra Market Revenue, 2011 2019 (USD Million)
4.2.7 Cialis
4.2.7.1 Global Cialis Market Revenue, 2011 2019 (USD Million)
4.2.8 Levitra/Staxyn
4.2.8.1 Global Levitra/Staxyn Market Revenue, 2011 2019 (USD Million)
4.3 Infertility Treatment/Assisted Reproductive Technologies (ART)
4.3.1 Global Infertility Treatment/ART Procedures Market Forecast, by Procedures, 2011 2019 (Number
of Procedures)
4.3.2 In Vitro Fertilization (IVF)
4.3.2.1 Global IVF Procedures Market Forecast, 2011 2019 (Number of Procedures)
4.3.3 Intracytoplasmic Sperm Injection (ICSI)
4.3.3.1 Global ICSI Procedures Market Forecast, 2011 2019 (Number of Procedures)
4.3.4 Zygote Intrafallopian Transfer (ZIFT)
4.3.4.1 Global ZIFT Procedures Market Forecast, 2011 2019 (Number of Procedures)
4.3.5 Gamete Intrafallopian Transfer (GIFT)
4.3.5.1 Global GIFT Procedures Market Forecast, 2011 2019 (Number of Procedures)
4.3.6 Intrauterine Insemination (IUI)
4.3.6.1 Global IUI Procedures Market Forecast, 2011 2019 (Number of Procedures)
Chapter 5 Global Human Reproductive Technologies Market, by Contraceptive Technologies

5.1 Overview
Human Reproductive
Technologies Market
5.1.1 Global Contraceptives Market Revenue, by Product Type, 2011 - 2019 (USD Million)
5.2 Contraceptive Drugs
5.2.1 Global Contraceptive Drugs Market Revenue, by Type, 2011 2019 (USD Million)
5.2.2 Oral Contraceptive Pills
5.2.2.1 Global Oral Contraceptive Pills Market Revenue, 2011 2019 (USD Million)
5.2.3 Contraceptive Injectables
5.2.3.1 Global Contraceptive Injectables Market Revenue, 2011 2019 (USD Million)
5.2.4 Topical Contraceptives
5.2.4.1 Global Topical Contraceptives Market Revenue, 2011 2019 (USD Million)
5.3 Contraceptive Devices
5.3.1 Global Contraceptive Devices Market Revenue, by Type, 2011 2019 (USD Million)
5.3.2 Male Contraceptive Devices (Male Condoms)
5.3.2.1 Global Male Contraceptive Devices (Male Condoms) Market Revenue, 2011 2019 (USD
Million)
5.3.3 Female Contraceptive Devices
5.3.3.1 Global Female Contraceptive Devices Market Revenue, 2011 2019 (USD Million)
Chapter 6 Global Human Reproductive Technologies Market Revenue, by Geography

6.1 Overview
6.2 North America
6.2.1 North America Human Reproductive Technologies Market Revenue, by Technology, 2011 2019
(USD Million)
6.2.2 North America Human Reproductive Technologies Market Revenue, 2011 2019 (USD Million)
6.3 Europe
Human Reproductive
Technologies Market
6.3.1 Europe Human Reproductive Technologies Market Revenue, by Technology, 2011 2019 (USD
Million)
6.3.2 Europe Human Reproductive Technologies Market Revenue, 2011 2019 (USD Million)
6.4 Asia-Pacific
6.4.1 Asia-Pacific Human Reproductive Technologies Market Revenue, by Technology, 2011 2019 (USD
Million)
6.4.2 Asia-Pacific Human Reproductive Technologies Market Revenue, 2011 2019 (USD Million)
6.5 Rest of the World (RoW)
6.5.1 RoW Human Reproductive Technologies Market Revenue, by Technology, 2011 2019 (USD
Million)
6.5.2 RoW Human Reproductive Technologies Market Revenue, 2011 2019 (USD Million)
Chapter 7 Recommendations
Chapter 8 Company Profiles

8.1 Abbott Laboratories, Inc.
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 Actavis, Inc.
10
Human Reproductive
Technologies Market

8.3 Bayer AG
8.4 Church & Dwight, Co. Inc.
8.4.1 Company Profile
8.5 Cook Medical, Inc.
8.6 Ferring International Center S.A.
11
Human Reproductive
Technologies Market

8.7 Johnson & Johnson
8.8 Merck & Co., Inc.
8.9 Merck Serono
8.10 Pfizer, Inc.
12
Human Reproductive
Technologies Market

8.11 Reckitt Benckiser Group plc
8.12 Teva Pharmaceutical Industries Ltd.
8.13 Warner Chilcott plc
13
Human Reproductive
Technologies Market
Browse Full Press Release @

http://www.transparencymarketresearch.com/pressrelease/human-reproductive-technologiesmarket.htm
About Us
Transparency Market Research is a market intelligence company providing global business information
reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers.
Contact

90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
Browse The Market Research Blog :
https://marketsresearchindustry.wordpress.com/
14

Transparency Market Research

Diunggah oleh

Informasi Dokumen

Deskripsi Asli:

Judul Asli

Hak Cipta

Format Tersedia

Bagikan dokumen Ini

Bagikan atau Tanam Dokumen

Opsi Berbagi

Apakah menurut Anda dokumen ini bermanfaat?

Apakah konten ini tidak pantas?

Hak Cipta:

Format Tersedia

Transparency Market Research

Diunggah oleh

Hak Cipta:

Format Tersedia

Transparency Market

125 Page Report